**Core Concept**
The prognosis of breast carcinoma largely depends on the histological subtype, tumor grade, and molecular characteristics. Among the various subtypes, some have a better prognosis due to their lower aggressiveness and higher likelihood of response to treatment.

**Why the Correct Answer is Right**
The best prognosis amongst the histological variants of breast carcinoma is seen with **Lobular Carcinoma In Situ (LCIS)**, also known as lobular neoplasia. LCIS is a non-invasive, non-obligate precursor lesion that does not invade the basement membrane. It is often detected incidentally on mammography or biopsy performed for another reason. The cells in LCIS are typically small and uniform, and the lesion is usually well-circumscribed. LCIS is associated with an increased risk of developing invasive breast cancer, but it is not a cancer itself. The prognosis is excellent, with a 5-year survival rate of nearly 100%.

**Why Each Wrong Option is Incorrect**
* **Option A:** Ductal Carcinoma In Situ (DCIS) has a worse prognosis than LCIS because it is a more advanced lesion that invades the basement membrane and has a higher potential for progression to invasive cancer.
* **Option B:** Invasive Lobular Carcinoma (ILC) has a worse prognosis than LCIS because it invades the basement membrane and has a higher potential for metastasis.
* **Option D:** Invasive Ductal Carcinoma (IDC) is the most common type of breast cancer and has a variable prognosis depending on the tumor grade and molecular characteristics.

**Clinical Pearl / High-Yield Fact**
LCIS is often associated with multiple breast cancers, and patients with LCIS have a higher risk of developing bilateral breast cancer. Therefore, it is essential to perform regular breast cancer screening and follow-up in patients with LCIS.

**Correct Answer: C. Invasive Lobular Carcinoma (ILC) is incorrect; the correct answer is actually not listed among the choices. However, based on the typical options for this question, the best answer is likely: A. Lobular Carcinoma In Situ (LCIS) has the best prognosis among the listed options.**